• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Alexza Pharmaceuticals

edit

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recent Milestones

edit

• 
  Alexza Pharmaceuticals received $1.01M in Venture Round funding. (5/12/10)
  Posted 5/14/10 at 2:03am via venturebeat.com
• 
  Alexza Pharmaceuticals acquired Symphony Allegro. (6/15/09)
  Posted 6/25/09 at 3:48pm via marketwatch.com
• 
  Alexza Pharmaceuticals added Guy Lethendre as Sr. Director Supply Chain. (10/1/05)
  Posted 5/2/13 at 12:18pm
• 
  Alexza Pharmaceuticals added Darl Moreland as Vice President, Quality.
  Posted 8/18/10 at 6:31pm
• 
  Alexza Pharmaceuticals added Thomas B. King as President & CEO.
  Posted 8/18/10 at 6:31pm
• 
  Alexza Pharmaceuticals added August J. Moretti as Senior Vice President and CFO.
  Posted 8/18/10 at 6:31pm
• 
  Alexza Pharmaceuticals added Sam Colella as Director.
  Posted 5/3/13 at 12:07am

Videos

Screenshots

edit

Sources

1. Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002 (marketwatch.com) [edit]
2. Alexza Pharma scores $1M to vaporize medications (deals.venturebeat.com) [edit]